Literature DB >> 18382931

Plasma homocysteine levels in patients with beta-thalassaemia major.

S Ozdem1, A Kupesiz, A Yesilipek.   

Abstract

OBJECTIVE: We investigated the level of homocysteine (HCY) and its relation with vitamin B12, folate and oxidative stress in patients with beta-thalassaemia major.
MATERIAL AND METHODS: Plasma HCY, methionine, advanced oxidation protein products (AOPP) and serum vitamin B12, folate, ferritin and total antioxidant capacity (TAC) were determined in 32 thalassaemic patients and 27 control subjects.
RESULTS: HCY (6.44+/-0.44 versus 8.71+/-0.57 micromol/L), methionine (12.57+/-1.8 versus 22.2+/-3.8 micromol/L), folate (9.14+/-0.48 versus 15.38+/-0.71 nmol/L) and TAC (0.34+/-0.03 versus 0.56+/-0.03 mmol/L) significantly decreased in thalassaemic patients, whereas AOPP (20.26+/-1.8 versus 11.30+/-0.2 micromol/L) and ferritin (3481.0+/-512 versus 46.9+/-4.6 ng/mL) significantly increased. Vitamin B12 levels were similar in both groups (259.1+/-16.6 versus 228.9+/-7.4 pmol/L).
CONCLUSIONS: These findings suggest that increased and uncompensated oxidative stress may lead to an increment in HCY catabolism in thalassaemic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382931     DOI: 10.1080/00365510701516343

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  Narrowband ultraviolet B phototherapy and serum folic acid level.

Authors:  Viroj Wiwanitkit
Journal:  Lasers Med Sci       Date:  2011-07-23       Impact factor: 3.161

2.  Effects of Alpha-Lipoic Acid Supplementation on Cardiovascular Disease Risk Factors in β-Thalassemia Major Patients: A Clinical Trial Crossover Study.

Authors:  Khadijeh Jamshidi; Hadi Abdollahzad; Mostafa Nachvak; Mansour Rezaei; Mohammad Reza Golpayegani; Elham Sharifi Zahabi
Journal:  J Blood Med       Date:  2020-05-07

3.  Nutritional Status in a Sample of Patients With β-Thalassemia Major.

Authors:  Irene Lidoriki; George Stavrou; Dimitrios Schizas; Maximos Frountzas; Lampros Fotis; Alkistis Kapelouzou; Smaro Kokkota; Barbara Fyntanidou; Katerina Kotzampassi
Journal:  Cureus       Date:  2022-08-14

4.  Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients.

Authors:  Mai A Abd-Elmawla; Sherine M Rizk; Ilham Youssry; Amira A Shaheen
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.